TP53 and neoplasm: In addition, the activation of the DAPK1/p53/Ets-1 signaling pathway exerted a transcriptional repression effect on IKKβ, which resulted in GADD45α accumulation and cell apoptosis under the exposure of tumor therapeutic agents, including arsenite.